These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 15297154

  • 1. Genetic contributions to Parkinson's disease.
    Huang Y, Cheung L, Rowe D, Halliday G.
    Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
    [Abstract] [Full Text] [Related]

  • 2. Heredity in Parkinson's disease: new findings.
    Lev N, Melamed E.
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of Parkinson's disease.
    Sherer TB, Betarbet R, Greenamyre JT.
    Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
    [Abstract] [Full Text] [Related]

  • 5. Gene-environment interactions in sporadic Parkinson's disease.
    Benmoyal-Segal L, Soreq H.
    J Neurochem; 2006 Jun; 97(6):1740-55. PubMed ID: 16805780
    [Abstract] [Full Text] [Related]

  • 6. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G, Schlüter OM, Südhof TC.
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [Abstract] [Full Text] [Related]

  • 7. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M, Romero-Ramos M, Carta M, Kirik D.
    Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM, Trojanowski JQ.
    Neuron; 2006 Oct 05; 52(1):33-8. PubMed ID: 17015225
    [Abstract] [Full Text] [Related]

  • 9. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.
    Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, Sidhu A.
    Ann N Y Acad Sci; 2004 Dec 05; 1035():231-49. PubMed ID: 15681811
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetics of Parkinson's disease.
    Gasser T.
    Adv Neurol; 2001 Dec 05; 86():23-32. PubMed ID: 11553982
    [Abstract] [Full Text] [Related]

  • 11. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW.
    Neurobiol Aging; 2007 Nov 05; 28(11):1709-17. PubMed ID: 16978743
    [Abstract] [Full Text] [Related]

  • 12. A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
    Gasser T, Müller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD.
    Nat Genet; 1998 Mar 05; 18(3):262-5. PubMed ID: 9500549
    [Abstract] [Full Text] [Related]

  • 13. [The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].
    Hattori N.
    Rinsho Shinkeigaku; 2004 Nov 05; 44(11):821-3. PubMed ID: 15651302
    [Abstract] [Full Text] [Related]

  • 14. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease.
    Scherzer CR, Jensen RV, Gullans SR, Feany MB.
    Hum Mol Genet; 2003 Oct 01; 12(19):2457-66. PubMed ID: 12915459
    [Abstract] [Full Text] [Related]

  • 15. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG.
    Pharmacol Ther; 2007 Jun 01; 114(3):327-44. PubMed ID: 17521740
    [Abstract] [Full Text] [Related]

  • 16. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
    Ekstrand MI, Galter D.
    Parkinsonism Relat Disord; 2009 Dec 01; 15 Suppl 3():S185-8. PubMed ID: 20082987
    [Abstract] [Full Text] [Related]

  • 17. Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
    Zhang Y, Dawson VL, Dawson TM.
    Neurobiol Dis; 2000 Aug 01; 7(4):240-50. PubMed ID: 10964596
    [Abstract] [Full Text] [Related]

  • 18. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
    Maguire-Zeiss KA, Short DW, Federoff HJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):18-23. PubMed ID: 15790526
    [Abstract] [Full Text] [Related]

  • 19. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK.
    J Neurochem; 2009 Jul 24; 110(1):208-19. PubMed ID: 19457126
    [Abstract] [Full Text] [Related]

  • 20. Alpha-synuclein and Parkinson's disease: a proteomic view.
    Fasano M, Lopiano L.
    Expert Rev Proteomics; 2008 Apr 24; 5(2):239-48. PubMed ID: 18466054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.